JPMorgan Chase & Co. lifted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 129.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,851 shares of the company’s stock after acquiring an additional 2,735 shares during the quarter. JPMorgan Chase & Co.’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $625,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in LABU. SG Americas Securities LLC boosted its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 49.3% during the third quarter. SG Americas Securities LLC now owns 3,199 shares of the company’s stock worth $412,000 after buying an additional 1,057 shares in the last quarter. McGuire Investment Group LLC boosted its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 3.9% during the third quarter. McGuire Investment Group LLC now owns 4,633 shares of the company’s stock worth $596,000 after buying an additional 175 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth approximately $43,000. Foundations Investment Advisors LLC boosted its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 13.0% during the third quarter. Foundations Investment Advisors LLC now owns 4,617 shares of the company’s stock worth $594,000 after buying an additional 530 shares in the last quarter. Finally, Traynor Capital Management Inc. boosted its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 6.7% during the third quarter. Traynor Capital Management Inc. now owns 10,763 shares of the company’s stock worth $1,386,000 after buying an additional 674 shares in the last quarter.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
Shares of NYSEARCA:LABU opened at $95.70 on Tuesday. Direxion Daily S&P Biotech Bull 3x Shares has a 1-year low of $78.46 and a 1-year high of $176.99. The company has a 50 day moving average price of $101.69 and a 200 day moving average price of $120.24.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Further Reading
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- The 3 Best Fintech Stocks to Buy Now
- Sizing Up a New Opportunity for NVIDIA Investors
- Stock Market Upgrades: What Are They?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.